McKesson Corporation (MCK) EPS Diluted: 38.38
Is McKesson Corporation’s EPS diluted high or low?
McKesson Corporation's EPS diluted of 38.38 is 151% above its 5-year average of 15.29, near the high end of its 5-year range (-27.02–38.38).
19.75% above its 12-month average of 32.05.
MCK EPS Diluted Chart
MCK Average EPS Diluted Chart
MCK Current vs Average EPS Diluted Chart
MCK EPS Diluted Metrics
EPS DILUTED
38.38
EPS DILUTED AVG TTM
32.05
EPS DILUTED AVG 3Y
27.88
EPS DILUTED AVG 5Y
15.29
EPS DILUTED AVG 10Y
11.78
EPS DILUTED AVG 15Y
12.27
EPS DILUTED AVG 20Y
4.40
CURRENT VS TTM AVG
+19.75%
CURRENT VS 3Y AVG
+37.65%
CURRENT VS 5Y AVG
+151.01%
CURRENT VS 10Y AVG
+225.73%
CURRENT VS 15Y AVG
+212.78%
CURRENT VS 20Y AVG
+771.48%
McKesson Corporation EPS Diluted Formula & Definition
EPS Diluted includes the effect of convertible securities, options, and other potential shares. Compare it with basic EPS to see the impact of potential dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
McKesson Corporation EPS Diluted FAQ
- What is the EPS diluted for McKesson Corporation (MCK)?
- The EPS diluted for MCK stock is 38.38.
- Is McKesson Corporation's EPS diluted high or low?
- McKesson Corporation's EPS diluted of 38.38 is 151% above its 5-year average of 15.29, near the high end of its 5-year range (-27.02–38.38).
- What is the TTM average EPS diluted for McKesson Corporation (MCK)?
- The TTM average EPS diluted for MCK stock is 32.05.
- What is the 3Y average EPS diluted for McKesson Corporation (MCK)?
- The 3Y average EPS diluted for MCK stock is 27.88.
- What is the 5Y average EPS diluted for McKesson Corporation (MCK)?
- The 5Y average EPS diluted for MCK stock is 15.29.
- What is the 10Y average EPS diluted for McKesson Corporation (MCK)?
- The 10Y average EPS diluted for MCK stock is 11.78.
- What is the 15Y average EPS diluted for McKesson Corporation (MCK)?
- The 15Y average EPS diluted for MCK stock is 12.27.
- What is the 20Y average EPS diluted for McKesson Corporation (MCK)?
- The 20Y average EPS diluted for MCK stock is 4.40.
McKesson Corporation EPS Diluted History
| DATE | EPS DILUTED |
|---|---|
| 2026-03-31 | 38.38 |
| 2025-03-31 | 25.72 |
| 2024-03-31 | 22.39 |
| 2023-03-31 | 25.04 |
| 2022-03-31 | 7.23 |
| 2021-03-31 | -27.02 |
| 2020-03-31 | 4.95 |
| 2019-03-31 | 0.17 |
| 2018-03-31 | 0.32 |
| 2017-03-31 | 22.73 |
| 2016-03-31 | 9.70 |
| 2015-03-31 | 6.27 |
| 2014-03-31 | 5.41 |
| 2013-03-31 | 5.59 |
| 2012-03-31 | 5.59 |
| 2011-03-31 | 4.57 |
| 2010-03-31 | 4.62 |
| 2009-03-31 | 2.95 |
| 2008-03-31 | 3.32 |
| 2007-03-31 | 2.99 |
| 2006-03-31 | 2.38 |
| 2005-03-31 | -0.53 |
| 2004-03-31 | 2.19 |
| 2003-03-31 | 1.88 |
| 2002-03-31 | 1.43 |
| 2001-03-31 | -0.17 |
| 2000-03-31 | 2.55 |
| 1999-03-31 | 0.31 |
| 1998-03-31 | 1.62 |
| 1997-03-31 | 0.80 |
Related Metrics
About McKesson Corporation
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Brian S. Tyler